首页> 外文期刊>Journal of the American Chemical Society >Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands
【24h】

Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands

机译:萘二酰亚胺配体靶向端粒G-四链体的结构基础

获取原文
获取原文并翻译 | 示例
       

摘要

The folding of the single-stranded 3' end of the human telomere into G-quadruplex arrangements inhibits the overhang from hybridizing with the RNA template of telomerase and halts telomere maintenance in cancer cells. The ability to thermally stabilize human telomeric DNA as a four-stranded G-quadruplex structure by developing selective small molecule compounds is a therapeutic path to regulating telomerase activity and thereby selectively inhibit cancer cell growth. The develop ment of compounds with the necessary selectivity and affinity to target parallel-stranded G-quadruplex structures has proved particularly challenging to date, relying heavily upon limited structural data. We report here on a structure-based approach to the design of quadruplex-binding ligands to enhance affinity and selectivity for human telomeric DNA. Crystal structures have been determined of complexes between a 22-mer intramolecular human telomeric quadruplex and two potent tetra-substituted naphthalene diimide compounds, functionalized with positively charged N-methyl-piperazine side-chains. These compounds promote parallel-stranded quadruplex topology, binding exclusively to the 3' surface of each quadruplex. There are significant differences between the complexes in terms of ligand mobility and in the interactions with quadruplex grooves. One of the two ligands is markedly less mobile in the crystal complex and is more quadruplex-stabilizing, forming multiple electrostatic/hydrogen bond contacts with quadruplex phosphate groups. The data presented here provides a structural rationale for the biophysical (effects on quadruplex thermal stabilization) and biological data (inhibition of proliferation in cancer cell lines and evidence of in vivo antitumor activity) on compounds in this series and, thus, for the concept of telomere targeting with DNA quadruplex-binding small molecules.
机译:将人类端粒的单链3'末端折叠成G-四链体排列,可防止突出端与端粒酶的RNA模板杂交,并终止癌细胞中端粒的维持。通过开发选择性的小分子化合物将人类端粒DNA稳定为四链G-四链体结构的能力,是调节端粒酶活性从而选择性抑制癌细胞生长的治疗途径。迄今为止,开发对目标平行链G-四链体结构具有必要选择性和亲和力的化合物特别困难,因为它严重依赖于有限的结构数据。我们在这里报告基于结构的方法来设计四链体结合配体,以增强对人类端粒DNA的亲和力和选择性。已经确定了22个分子内人类端粒四聚体和两个带正电荷的N-甲基-哌嗪侧链官能化的有效四取代萘二酰亚胺化合物之间的复合物的晶体结构。这些化合物可促进平行链四链体拓扑,仅与每个四链体的3'表面结合。在配体之间以及在与四链体凹槽的相互作用方面,复合物之间存在显着差异。两种配体之一在晶体络合物中的移动性明显较低,并且具有更高的四链体稳定性,与四链体磷酸基团形成多个静电/氢键接触。此处提供的数据为该系列化合物的生物物理(对四链体热稳定性的影响)和生物学数据(抑制癌细胞系的增殖以及体内抗肿瘤活性的证据)提供结构上的理论依据,从而为端粒靶向与DNA四链体结合的小分子。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2012年第5期|p.2723-2731|共9页
  • 作者单位

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

    CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, London, WC1N 1AX, United Kingdom;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:13:23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号